Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus

By afschroeder • January 10, 2026

Alban J, Bowen RC, Reichstein DA, McKean M, Lutzky J, Weis E, Carvajal RD, Dulka S, Morse BG, Butler MO, Rapisuwon S, Kim KB, Chandrasekaran S, Warner AB, Zager JS, Chmielowski B, Patel SP, Hernandez-Aya LF, Correa ZM, Fecher LA, Najjar YG, Montazeri K, Shoushtari AN, Javed A, Gombos DS, Salama AKS, Tsai K, Miller FH, Khushalani N, Seedor RS, Lipson EJ, Reddy SA, Buchbinder E, Bhatia S, Pavlick A, Mehmi I, Aaberg T, Ikeguchi AP, Kim IK, Walter SD, Singh AD, Sullivan RJ, Choi JS, Williams BK Jr, Orloff M, Mruthyunjaya P, Schollenberger MD, Gandhi N, Harbour JW, Chandra S. Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. Cancers (Basel). 2025 Dec 30;18(1):121. doi: 10.3390/cancers18010121. PMID: 41514630; PMCID: PMC12784650.

Tags: gene-expression profile, Hematology/Oncology, metastatic uveal melanoma surveillance, PRAME, Publications, uveal melanoma

The Next Chapter of Cancer Immunology Research

Jaffee EM, Ribas A. The Next Chapter of Cancer Immunology Research. Cancer Immunol Res. 2026 Jan 8;14(1):8-9. doi: 10.1158/2326-6066.CIR-25-1391. PMID: 41502310.

Transarterial Radioembolization (TARE) Complicated by a Mycotic Aneurysm and Bleeding: A Case Presentation and Literature Review

Hu EH. Transarterial Radioembolization (TARE) Complicated by a Mycotic Aneurysm and Bleeding: A Case Presentation and Literature Review. Cureus. 2025 Dec 4;17(12):e98484. doi: 10.7759/cureus.98484. PMID:[...]

CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming

Wang MR, Mu W, Zhen A, Kitchen SG. CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming. Trends Biotechnol. 2026 Jan 5:S0167-7799(25)00499-8.[...]